Transformative Growth Ahead for Immunotherapy Drugs as Precision Medicine, AI, and Biologics Propel Market Innovation and ...

Mice lacking the extracellular matrix protein tenascin-C showed a reduced ability to repair muscular damage compared to controls.

Researchers say this is the first combination therapy that targets two different cancer survival mechanism: PARP and WNT signaling.